On Tuesday, Shares of Take-Two Interactive Software Inc. (NASDAQ:TTWO), gained 18.26% to $28.62.
Take-Two Interactive Software, and Firaxis Games declared Sid Meier’s Civilization®: Beyond Earth™ – Rising Tide, the expansion pack for 2014’s turn-based strategy title, Civilization: Beyond Earth, is presently in development for Windows-based PC. Created by Firaxis Games, Rising Tide will enhance the Beyond Earth experience by adding a variety of new gameplay capabilities and providing near limitless ways for players to create a new future for humanity on an alien planet. The expansion pack is presently planned for release in fall 2015.
Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment for consumers worldwide. The company offers its products under the Rockstar Games and 2K labels. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead names through developing sequels, offering downloadable episodes and content, and releasing titles for smartphones and tablets.
Shares of CenturyLink, Inc. (NYSE:CTL), declined -1.28% to $33.96, during its last trading session, hitting its lowest level.
CenturyLink, declared it has been positioned by industry analyst firm Gartner, Inc. as a visionary in the 2015 Magic Quadrant for Cloud Infrastructure as a Service, Worldwide, report.
With the recent acquisitions of Orchestrate, Cognilytics and DataGardens, in addition to global expansions of its cloud node locations and data center footprint, CenturyLink continues to advance its managed services, cloud and colocation offerings for enterprises.
Gartner analysts Lydia Leong, Douglas Toombs and Bob Gill authored the Magic Quadrant for Cloud Infrastructure as a Service, Worldwide, report, published on May 18, 2015. Evaluation for the report was based on vendors’ completeness of vision and ability to execute.
CenturyLink, Inc. provides various communications services to residential, business, governmental, and wholesale customers in the United States. It operates through two segments, Business and Consumer. The company offers broadband services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; private line services for transmission of large amounts of data between sites; and multi-protocol label switching, a data networking technology to support real-time voice and video.
At the end of Tuesday’s trade, Shares of Cinedigm Corp. (NASDAQ:CIDM), lost -1.24% to $0.94.
Cinedigm, declared a plan to enhance its Board of Directors to better support the Company’s content distribution business and rapidly evolving niche over-the-top (OTT) digital network business. The Company intends to add two to four new directors, counting a new Chairman of the Board. Cinedigm has engaged Korn Ferry, a leading internationally recognized executive search and advisory firm, to assist in the search for new Board candidates.
Over the last four years, Cinedigm has transformed from a digital cinema deployment and financing entity to a leading independent distributor of content across all platforms in the U.S., counting the emerging OTT space. In recent months, the Company’s independent niche OTT business has accelerated significantly, counting the launch of CONtv on March 3rd, the planned launch of the faith and family Dove Channel this summer, the ongoing growth of the documentary-focused channel Docurama and several more channels in development.
Cinedigm Corp. distributes independent movie, television, and other short form content in the Unites States. It manages a library of distribution rights to about 52,000 titles and episodes released across theatrical, digital, physical, home, and mobile entertainment platforms, in addition to services digital cinema assets on about 12,000 movies screens.
Finally, Hospira Inc. (NYSE:HSP), ended its last trade with -0.05% loss, and closed at $88.21
Hospira, declared that Hospira shareholders voted in favor of the proposal to adopt the merger agreement with Pfizer Inc. at a special meeting of stockholders held recently, May 13, 2015, in Denver, Colo.
On Feb. 5, 2015, Hospira and Pfizer Inc. declared they had reached a merger agreement under which Pfizer will acquire Hospira for $90 per share in cash for a total enterprise value of about $17 billion. The merger is subject to customary closing conditions, one of which was approval of the merger by Hospira’s shareholders. Additional closing conditions to be met comprise obtaining regulatory approvals in several jurisdictions.
At the Special Meeting recently, 140.8 million shares were voted in favor of the merger agreement, or 99.4 percent of shares voted for the merger proposal and about 81.5 percent of Hospira’s outstanding shares.
Hospira, Inc. provides injectable drugs and infusion technologies to develop, manufacture, distribute, and market products worldwide. The company operates through Americas, EMEA, and APAC segments. It provides specialty injectable pharmaceuticals, which comprise about 200 injectable generic drugs in multiple dosages and formulations; and proprietary specialty injectables, such as Precedex, a proprietary drug for sedation.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
